AAAAAA

   
Results: 1-23 |
Results: 23
Specific T cell therapy in leukemia
Authors: Marijt, WAF Falkenburg, JHF
Citation: Waf. Marijt et Jhf. Falkenburg, Specific T cell therapy in leukemia, J HEMATH ST, 10(4), 2001, pp. 493-500
Engraftment potential into NOD/SCID mice of CD34(+) cells derived from human fetal liver as compared to fetal bone marrow
Authors: Wilpshaar, J Noort, WA Kanhai, HHH Willemze, R Falkenburg, JHF
Citation: J. Wilpshaar et al., Engraftment potential into NOD/SCID mice of CD34(+) cells derived from human fetal liver as compared to fetal bone marrow, HAEMATOLOG, 86(10), 2001, pp. 1021-1028
Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice
Authors: Nijmeijer, BA Mollevanger, P van Zelderen-Bhola, SL Kluin-Nelemans, HC Willemze, R Falkenburg, JHF
Citation: Ba. Nijmeijer et al., Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice, EXP HEMATOL, 29(3), 2001, pp. 322-329
Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord bloodas compared to adult sources
Authors: Noort, WA Wilpshaar, J Hertogh, CDP Rad, M Lurvink, EGA van Luxemburg-Heijs, SAP Zwinderman, K Verwey, RA Willemze, R Falkenburg, JHF
Citation: Wa. Noort et al., Similar myeloid recovery despite superior overall engraftment in NOD/SCID mice after transplantation of human CD34(+) cells from umbilical cord bloodas compared to adult sources, BONE MAR TR, 28(2), 2001, pp. 163-171
Graft outcome - Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short-and long-term outcome
Authors: Barge, RMY Brouwer, RE Beersma, MFC Starrenburg, CWJ Zwinderman, AH Hale, G Waldmann, H den Ottolander, GJ Falkenburg, JHF Willemze, R Fibbe, WE
Citation: Rmy. Barge et al., Graft outcome - Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short-and long-term outcome, BONE MAR TR, 27(10), 2001, pp. 1053-1058
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex
Authors: Heemskerk, MHM de Paus, RA Lurvink, EGA Koning, F Mulder, A Willemze, R van Rood, JJ Falkenburg, JHF
Citation: Mhm. Heemskerk et al., Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex, P NAS US, 98(12), 2001, pp. 6806-6811
Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis
Authors: Brouwer, RE Hoefnagel, J van der Burg, BB Jedema, I Zwinderman, KH Starrenburg, ICW Kluin-Nelemans, HC Barge, RMY Willemze, R Falkenburg, JHF
Citation: Re. Brouwer et al., Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis, BR J HAEM, 115(2), 2001, pp. 298-308
HLA-DR4 is associated with a diminished risk of the development of chronicmyeloid leukemia (CML)
Authors: Posthuma, EFM Falkenburg, JHF Apperley, JF Gratwohl, A Hertenstein, B Schipper, RF Oudshoorn, M von Biezen, JH Hermans, J Willemze, R Roosnek, E Niederwieser, D
Citation: Efm. Posthuma et al., HLA-DR4 is associated with a diminished risk of the development of chronicmyeloid leukemia (CML), LEUKEMIA, 14(5), 2000, pp. 859-862
The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses
Authors: Brouwer, RE van der Hoorn, M Kluin-Nelemans, HC van Zelderen-Bhola, S Willemze, R Falkenburg, JHF
Citation: Re. Brouwer et al., The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses, HUMAN IMMUN, 61(6), 2000, pp. 565-574
UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterizationof the critical polymorphic amino acid residues for T-cell recognition
Authors: Vogt, MHJ Goulmy, E Kloosterboer, FM Blokland, E de Paus, RA Willemze, R Falkenburg, JHF
Citation: Mhj. Vogt et al., UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterizationof the critical polymorphic amino acid residues for T-cell recognition, BLOOD, 96(9), 2000, pp. 3126-3132
Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice
Authors: Wilpshaar, J Falkenburg, JHF Tong, X Noort, WA Breese, R Heilman, D Kanhai, H Orschell-Traycoff, CM Srour, EF
Citation: J. Wilpshaar et al., Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice, BLOOD, 96(6), 2000, pp. 2100-2107
DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection
Authors: Vogt, MHJ de Paus, RA Voogt, PJ Willemze, R Falkenburg, JHF
Citation: Mhj. Vogt et al., DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection, BLOOD, 95(3), 2000, pp. 1100-1105
Association of stress during delivery with increased numbers of nucleated cells and hematopoietic progenitor cells in umbilical cord blood
Authors: Lim, FTH Scherjon, SA van Beckhoven, JM Brand, A Kanhai, HHH Hermans, JMH Falkenburg, JHF
Citation: Fth. Lim et al., Association of stress during delivery with increased numbers of nucleated cells and hematopoietic progenitor cells in umbilical cord blood, AM J OBST G, 183(5), 2000, pp. 1144-1151
Leukemia-reactive T cells in adoptive immunotherapy for relapsed leukemia after allogeneic transplantation
Authors: Falkenburg, JHF Willemze, R
Citation: Jhf. Falkenburg et R. Willemze, Leukemia-reactive T cells in adoptive immunotherapy for relapsed leukemia after allogeneic transplantation, BAS CLIN ON, 22, 2000, pp. 359-368
Impaired expression of CD28 on T cells in hairy cell leukemia
Authors: van de Corput, L Falkenburg, JHF Kester, MGD Willemze, R Kluin-Nelemans, JC
Citation: L. Van De Corput et al., Impaired expression of CD28 on T cells in hairy cell leukemia, CLIN IMMUNO, 93(3), 1999, pp. 256-262
Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease
Authors: Mutis, T Gillespie, G Schrama, E Falkenburg, JHF Moss, P Goulmy, E
Citation: T. Mutis et al., Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease, NAT MED, 5(7), 1999, pp. 839-842
The number of nucleated cells reflects: the hematopoietic content of umbilical cord blood for transplantation
Authors: Lim, FTH van Beckhoven, JM Brand, A Kluin-Nelemans, JC Hermans, JMH Willemze, R Kanhai, HHH Falkenburg, JHF
Citation: Fth. Lim et al., The number of nucleated cells reflects: the hematopoietic content of umbilical cord blood for transplantation, BONE MAR TR, 24(9), 1999, pp. 965-970
Aplastic anaemia in donor cells 14 years after bone-marrow transplant
Authors: Melenhorst, JJ van Luxemburg-Heijs, SAP Landegent, JE Willemze, R Fibbe, WE Falkenburg, JHF
Citation: Jj. Melenhorst et al., Aplastic anaemia in donor cells 14 years after bone-marrow transplant, LANCET, 353(9169), 1999, pp. 2037-2038
Mismatched transplants for refractory lymphoma?
Authors: Falkenburg, JHF Kluin-Nelemans, HC
Citation: Jhf. Falkenburg et Hc. Kluin-nelemans, Mismatched transplants for refractory lymphoma?, LANCET, 353(9166), 1999, pp. 1725-1726
Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes
Authors: Falkenburg, JHF Wafelman, AR Joosten, P Smit, WM van Bergen, CAM Bongaerts, R Lurvink, E van der Hoorn, M Kluck, P Landegent, JE Kluin-Nelemans, HC Fibbe, WE Willemze, R
Citation: Jhf. Falkenburg et al., Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes, BLOOD, 94(4), 1999, pp. 1201-1208
HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia
Authors: Posthuma, EFM Falkenburg, JHF Apperley, JF Gratwohl, A Roosnek, E Hertenstein, B Schipper, RF Schreuder, GMT D'Amaro, J Oudshoorn, M von Biezen, JH Hermans, J Willemze, R Niederwieser, D
Citation: Efm. Posthuma et al., HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia, BLOOD, 93(11), 1999, pp. 3863-3865
Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones
Authors: van de Corput, L Kluin-Nelemans, HC Kester, MGD Willemze, R Falkenburg, JHF
Citation: L. Van De Corput et al., Hairy cell leukemia-specific recognition by multiple autologous HLA-DQ or DP-restricted T-cell clones, BLOOD, 93(1), 1999, pp. 251-259
Umbilical cord blood as an alternative source of haematopoietic stem cellsfor transplantation
Authors: Jacobs, HCJM Falkenburg, JHF
Citation: Hcjm. Jacobs et Jhf. Falkenburg, Umbilical cord blood as an alternative source of haematopoietic stem cellsfor transplantation, DEV HEMATOL, 33, 1998, pp. 175-181
Risultati: 1-23 |